2023-08-01 08:01:18 ET
- uniQure press release ( NASDAQ: QURE ): Q2 EPS of -$1.44 may not be comparable to consensus of $2.72.
- Revenue of $2.4M (+380.0% Y/Y).
- Revenue for the three months ended June 30, 2023 was $2.4 million, compared to $0.5 million in the same period in 2022. The increase is primarily a result of contract manufacturing revenues of $1.3 million recognized in the current period related to contract manufacturing HEMGENIX for CSL Behring and an increase in license revenues of $0.8 million.
For further details see:
uniQureEPS of -$1.44, revenue of $2.4M